T cell effects and mechanisms in immunotherapy of head and neck tumors
Abstract Head and neck tumors (HNCs) are a common tumor in otorhinolaryngology head and neck surgery, accounting for 5% of all malignant tumors in the body and are the sixth most common malignant tumor worldwide. In the body, immune cells can recognize, kill, and remove HNCs. T cell-mediated antitum...
Main Authors: | Yizhen Xiang, Mengdan Gong, Yongqin Deng, Hongli Wang, Dong Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-023-01070-y |
Similar Items
-
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
by: Elena Shklovskaya, et al.
Published: (2021-06-01) -
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells
by: Steven F. Gameiro, et al.
Published: (2019-08-01) -
Discovery of a Novel MHC Class I Lineage in Teleost Fish which Shows Unprecedented Levels of Ectodomain Deterioration while Possessing an Impressive Cytoplasmic Tail Motif
by: Unni Grimholt, et al.
Published: (2019-09-01) -
Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma
by: Elena Shklovskaya, et al.
Published: (2020-11-01) -
Immunotherapy in head and neck cancer – scientific rationale, current treatment options and future directions
by: Uta Rothschild, et al.
Published: (2018-05-01)